Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia · Delayed Price · Currency is SAR 22.90
-0.08 (-0.35%)
Sep 6, 2026, 2:23 PM AST
TADAWUL:9620 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 12.93 | 10.84 | 18.24 | 3.68 | 5.74 |
Cash & Short-Term Investments | 12.93 | 10.84 | 18.24 | 3.68 | 5.74 |
Cash Growth | -28.60% | -40.56% | 396.05% | -35.90% | - |
Accounts Receivable | 5.23 | 0.7 | 0.34 | 0.3 | 0.3 |
Other Receivables | - | 0.11 | 0.28 | 0.04 | 0.02 |
Receivables | 5.23 | 0.81 | 0.62 | 0.34 | 0.32 |
Inventory | 3.13 | 3.56 | 1.72 | 1.5 | 0.68 |
Prepaid Expenses | - | 0.07 | 0.03 | - | - |
Other Current Assets | - | 5.31 | 0.59 | 0.28 | 0.66 |
Total Current Assets | 21.28 | 20.6 | 21.2 | 5.8 | 7.39 |
Property, Plant & Equipment | 17.45 | 15.04 | 12.08 | 12.86 | 7.51 |
Total Assets | 38.73 | 35.65 | 33.28 | 18.66 | 14.9 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 2.39 | 0.25 | 0.27 | 0.34 | 0.44 |
Accrued Expenses | - | 0.98 | 0.79 | 0.84 | 0.62 |
Current Portion of Leases | 0.31 | 0.23 | 0.31 | 0.23 | 0.5 |
Current Income Taxes Payable | 0.08 | 0.55 | 0.26 | 0.1 | 0.12 |
Other Current Liabilities | - | - | - | 0.01 | 2.69 |
Total Current Liabilities | 2.78 | 2.01 | 1.64 | 1.52 | 4.37 |
Long-Term Leases | 2.69 | 1.29 | 1.5 | 1.69 | 2.13 |
Pension & Post-Retirement Benefits | 1.56 | 1.46 | 1.23 | 1.06 | 1.04 |
Total Liabilities | 7.04 | 4.76 | 4.36 | 4.27 | 7.54 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 25 | 25 | 12.5 | 10 | 4.9 |
Additional Paid-In Capital | - | - | 10.15 | - | - |
Retained Earnings | 6.7 | 5.89 | 6.27 | 4.39 | 2.46 |
Shareholders' Equity | 31.7 | 30.89 | 28.92 | 14.39 | 7.36 |
Total Liabilities & Equity | 38.73 | 35.65 | 33.28 | 18.66 | 14.9 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 3.01 | 1.51 | 1.8 | 1.93 | 2.62 |
Net Cash (Debt) | 9.92 | 9.33 | 16.44 | 1.75 | 3.11 |
Net Cash Growth | -39.53% | -43.24% | 838.03% | -43.71% | - |
Net Cash Per Share | 3.97 | 3.73 | 6.58 | 1.19 | - |
Filing Date Shares Outstanding | 2.5 | 2.5 | 2.5 | 1.48 | - |
Total Common Shares Outstanding | 2.5 | 2.5 | 2.5 | 1.48 | - |
Working Capital | 18.51 | 18.6 | 19.56 | 4.28 | 3.02 |
Book Value Per Share | 12.68 | 12.36 | 11.57 | 9.71 | - |
Tangible Book Value | 31.7 | 30.89 | 28.92 | 14.39 | 7.36 |
Tangible Book Value Per Share | 12.68 | 12.36 | 11.57 | 9.71 | - |
Land | - | 7.79 | 5.13 | 5.13 | - |
Buildings | - | 3.36 | 3.36 | 3.36 | - |
Machinery | - | 6.71 | 6.46 | 6.27 | 6.17 |
Construction In Progress | - | 1.24 | - | - | - |
Leasehold Improvements | - | 1.14 | 1.13 | 1.11 | 2.55 |